ProRx LLC: Drug Recall
Recall #D-0118-2026 · 10/15/2025
Class II: Risk
Recall Details
- Recall Number
- D-0118-2026
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- ProRx LLC
- Status
- Ongoing
- Date Initiated
- 10/15/2025
- Location
- Exton, PA, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2,649 vials
Reason for Recall
Lack of Assurance of Sterility
Product Description
Semaglutide Injection, 2.5mg/1mL (2.5 mg/mL), 1mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-225-06
Distribution Pattern
TX and UT
Other Recalls by ProRx LLC
- Class II: Risk 10/15/2025
- Class II: Risk 10/15/2025
- Class II: Risk 10/15/2025
- Class II: Risk 10/15/2025
- Class II: Risk 10/15/2025
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.